Group 1 - IDEAYA Biosciences, Inc. is participating in several upcoming investor relations events, including the Cantor Global Healthcare Conference on September 3, 2025, and the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025 [1][2] - The company will host an R&D Day on September 8, 2025, to share clinical data updates, outline upcoming catalysts, and review its long-term portfolio strategy [1][6] - Key opinion leader Dr. Arun D. Singh will participate in the R&D Day, providing insights alongside the company's leadership team [6] Group 2 - IDEAYA is focused on precision medicine in oncology, aiming to discover and develop targeted therapies for cancer [3] - The company integrates small-molecule drug discovery, structural biology, and bioinformatics to develop tailored therapies aligned with genetic disease drivers [3] - IDEAYA has a pipeline that includes product candidates focused on synthetic lethality and antibody-drug conjugates for molecularly defined solid tumor indications [3]